ROI Financial Advisors LLC Makes New $230,000 Investment in Oracle Corporation $ORCL

ROI Financial Advisors LLC bought a new stake in shares of Oracle Corporation (NYSE:ORCL) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,051 shares of the enterprise software provider’s stock, valued at approximately $230,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Nuveen LLC purchased a new stake in Oracle in the first quarter worth $732,692,000. Vanguard Group Inc. grew its holdings in shares of Oracle by 2.2% in the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock worth $22,498,982,000 after purchasing an additional 3,513,464 shares during the last quarter. Kingstone Capital Partners Texas LLC bought a new position in shares of Oracle in the second quarter worth about $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Oracle by 79.2% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock worth $648,572,000 after buying an additional 2,049,687 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in Oracle by 840.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock valued at $463,380,000 after buying an additional 1,894,157 shares in the last quarter. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Barclays raised their target price on shares of Oracle from $367.00 to $400.00 and gave the stock an “overweight” rating in a research report on Friday, October 17th. Sanford C. Bernstein increased their price objective on Oracle from $363.00 to $364.00 and gave the stock an “outperform” rating in a research note on Friday, September 26th. Citigroup restated a “buy” rating on shares of Oracle in a report on Friday, October 10th. Robert W. Baird assumed coverage on Oracle in a research report on Wednesday, October 8th. They set an “outperform” rating and a $365.00 target price for the company. Finally, Morgan Stanley increased their price target on Oracle from $246.00 to $320.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 23rd. Three analysts have rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating, ten have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Oracle presently has an average rating of “Moderate Buy” and a consensus price target of $323.69.

Insider Buying and Selling

In other Oracle news, EVP Stuart Levey sold 19,758 shares of Oracle stock in a transaction on Friday, October 10th. The shares were sold at an average price of $300.00, for a total value of $5,927,400.00. Following the transaction, the executive vice president directly owned 18,429 shares of the company’s stock, valued at approximately $5,528,700. The trade was a 51.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Naomi O. Seligman sold 2,222 shares of the stock in a transaction on Friday, September 26th. The shares were sold at an average price of $288.91, for a total value of $641,958.02. Following the sale, the director owned 29,225 shares of the company’s stock, valued at approximately $8,443,394.75. This represents a 7.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 204,254 shares of company stock valued at $60,227,807 over the last quarter. Insiders own 40.90% of the company’s stock.

Oracle Trading Up 0.8%

ORCL opened at $250.26 on Thursday. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33. The firm has a market cap of $713.44 billion, a price-to-earnings ratio of 57.93, a PEG ratio of 2.96 and a beta of 1.53. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $345.72. The stock has a fifty day moving average price of $278.97 and a 200-day moving average price of $228.97.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. Oracle’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, equities research analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 23rd. Investors of record on Thursday, October 9th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.8%. Oracle’s dividend payout ratio is presently 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.